Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians worldwide. It operates through European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development segments. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and locomotion and pain management products for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for dogs and cats under the Specific brand; distributes veterinary pharmaceuticals and equipment; and offers financial services. The company markets its products through wholesaler and distributor networks. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.
Industry, Sector and Symbol
Stock Exchange LON
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
Current SymbolLON:DPH
Previous Symbol
CUSIPN/A
Phone+44-1606-814730
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees1,437
Outstanding SharesN/A
Market Cap£0.00
OptionableNot Optionable
Dechra Pharmaceuticals (LON:DPH) Frequently Asked Questions
What is Dechra Pharmaceuticals' stock symbol?
Dechra Pharmaceuticals trades on the London Stock Exchange (LON) under the ticker symbol "DPH."
How often does Dechra Pharmaceuticals pay dividends? What is the dividend yield for Dechra Pharmaceuticals?
Dechra Pharmaceuticals declared a dividend on Monday, September 3rd. Stockholders of record on Thursday, October 25th will be paid a dividend of GBX 18.17 per share on Friday, November 16th. This represents a dividend yield of 0.74%. The ex-dividend date is Thursday, October 25th. This is a positive change from Dechra Pharmaceuticals's previous dividend of $7.33. The official announcement can be seen at this link. View Dechra Pharmaceuticals' Dividend History.
What price target have analysts set for DPH?
3 brokerages have issued 1 year price targets for Dechra Pharmaceuticals' shares. Their forecasts range from GBX 2,400 to GBX 2,950. On average, they expect Dechra Pharmaceuticals' share price to reach GBX 2,660.33 in the next twelve months. This suggests a possible upside of 27.7% from the stock's current price. View Analyst Price Targets for Dechra Pharmaceuticals.
What is the consensus analysts' recommendation for Dechra Pharmaceuticals?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dechra Pharmaceuticals in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Dechra Pharmaceuticals.
Has Dechra Pharmaceuticals been receiving favorable news coverage?
Press coverage about DPH stock has been trending neutral on Sunday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Dechra Pharmaceuticals earned a daily sentiment score of 0.2 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 9.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days.
Who are some of Dechra Pharmaceuticals' key competitors?
Some companies that are related to Dechra Pharmaceuticals include Allergy Therapeutics (AGY), Antisense Therapeutics (ANP), AstraZeneca (AZN), Avivagen (VIV), Bayer (BAYN), Bayer (BAYN), BEXIMCO PHARMAC/S GDR REGS (BXP), Cathay International (CTI), China Pharma (CPHI), Eco Animal Health Group (EAH), Futura Medical (FUM), GlaxoSmithKline (GSK), Hutchison China MediTech (HCM), Mayne Pharma Group (MYX) and N4 Pharma (N4P).
Who are Dechra Pharmaceuticals' key executives?
Dechra Pharmaceuticals' management team includes the folowing people:
- Mr. Ian D. Page, CEO, MD & Exec. Director (Age 57)
- Mr. Richard John Cotton, CFO & Director (Age 57)
- Dr. Anthony Gerard Griffin, MD of Dechra Veterinary Products for Europe & Exec. Director (Age 55)
- Ms. Andrea Dodds, Group Marketing Director
- Ms. Katy Clough, Group HR Director
How do I buy shares of Dechra Pharmaceuticals?
Shares of DPH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Dechra Pharmaceuticals' stock price today?
One share of DPH stock can currently be purchased for approximately GBX 2,084.
What is Dechra Pharmaceuticals' official website?
How can I contact Dechra Pharmaceuticals?
Dechra Pharmaceuticals' mailing address is 24 Cheshire Business Park Cheshire Avenue, NORTHWICH, CW9 7UA, United Kingdom. The company can be reached via phone at +44-1606-814730.
MarketBeat Community Rating for Dechra Pharmaceuticals (LON DPH)
MarketBeat's community ratings are surveys of what our community members think about Dechra Pharmaceuticals and other stocks. Vote "Outperform" if you believe DPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
